Modest Weight Loss Plus Few GI Upsets With Amylin Injectable
NEW ORLEANS — Petrelintide, an investigational long-acting amylin analog, induced significant weight loss with minimal side effects in the global phase II ZUPREME-1 study. By week 28, all five investigational…









